SSH -GREENSBORO — History
CCN 342020 | 3-year financial timeline | COVID resilience: 26/100
🛡️ Public data only — no PHI permitted on this instance.
$16M
Latest Revenue (FY2022)
-5.0%
Revenue CAGR (3yr)
-16.1%
Financial Timeline
| Metric | FY2020 | FY2021 | FY2022 | YoY (Latest) | CAGR |
|---|---|---|---|---|---|
| Net Patient Revenue | $17M | $16M | $16M | -1.9% | -5.0% |
| Operating Expenses | $16M | $18M | $18M | -2.0% | +7.3% |
| Operating Margin | 9.0% | -16.1% | -16.1% | +0.4% | +0.0% |
| Net Income | $2M | $-3M | $-3M | +2.3% | +0.0% |
| Licensed Beds | 30 | 30 | 30 | +0.0% | +0.0% |
| Total Patient Days | 10,567 | 9,923 | 9,852 | -0.7% | -3.4% |
| Medicare Day % | 49% | 43% | 50% | +16.0% | +1.5% |
| Medicaid Day % | nan% | nan% | nan% | +nan% | +nan% |
COVID Impact & Recovery
Resilience Score: 26/100 — Distressed — significant COVID damage
Revenue recovery from FY2020 to FY2022: -9.7% ($17M → $16M)
FY2020 captured the initial COVID shock. Slow recovery suggests structural challenges beyond COVID.
Trend Summary
Revenue▼ Declining
Operating Margin▼ Declining
Beds▶ Stable
Medicare Mix▼ Declining
vs State Average ()
Revenue Growth
-5.0%
This Hospital
+7.6%
State Avg
Latest Margin
-16.1%
This Hospital
-4.6%
State Avg
Projections (FY2023-2025)
Extrapolated from 3-year trend using linear projection. Does not account for regulatory or market changes.
| Year | Revenue (proj) | Margin (proj) |
|---|---|---|
| FY2023 (proj) | $15M | -28.6% |
| FY2024 (proj) | $14M | -41.2% |
| FY2025 (proj) | $13M | -53.7% |